Discover
COCP
Cocrystal Pharma, Inc.
1.21
2 x 0.81
2 x 1.53
bid
ask
+
0.07
6.14%
2 @ 04:00 AM
1.19 -0.02 (1.65%)
| Ytd | 23.47% | |
| 1y | -4.72% |
1.14
day range
1.25
0.76
52 week range
2.03
| Open | 1.14 | Prev Close | 1.14 | Low | 1.14 | High | 1.25 | Mkt Cap | 23.31M |
| Vol | 176.49K | Avg Vol | 59.65K | EPS | -0.75 | P/E | N/A | Forward P/E | -1.22 |
| Beta | 1.48 | Short Ratio | 0.12 | Inst. Own | 6.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.06 | 200-d Avg | 1.10 | 1yr Est | 8.00 |
| Income Statement | |||
| Operating Expenses | 3.29M | ||
| Research and Development Expense | 2.14M | ||
| Selling, General and Administrative Expense | 1.15M | ||
| Operating Income | -3.29M | ||
| Net Income | -3.16M | ||
| Net Income Common Stock | -3.16M | ||
| Net Income Common Stock (USD) | -3.16M | ||
| Consolidated Income | -3.16M | ||
| Earnings per Basic Share | -0.23 | ||
| Earnings per Basic Share (USD) | -0.23 | ||
| Earnings per Diluted Share | -0.23 | ||
| Earning Before Interest & Taxes (EBIT) | -3.16M | ||
| Earning Before Interest & Taxes (USD) | -3.16M | ||
| Weighted Average Shares | 13.79M | ||
| Weighted Average Shares Diluted | 13.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.36M | ||
| Cash and Equivalents (USD) | 2.36M | ||
| Current Assets | 3.24M | ||
| Property, Plant & Equipment Net | 1.30M | ||
| Total Assets | 4.65M | ||
| Debt Current | 352.00K | ||
| Total Debt | 1.34M | ||
| Current Liabilities | 2.62M | ||
| Debt Non-Current | 989.00K | ||
| Total Liabilities | 3.61M | ||
| Accumulated Retained Earnings (Deficit) | -347.71M | ||
| Shareholders Equity | 1.04M | ||
| Shareholders Equity (USD) | 1.04M | ||
| Assets Non-Current | 1.41M | ||
| Total Debt (USD) | 1.34M | ||
| Liabilities Non-Current | 989.00K | ||
| Trade and Non-Trade Payables | 2.26M | ||
| Tax Assets | 701.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 12.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.52M | ||
| Net Cash Flow from Operations | -2.52M | ||
| Share Based Compensation | 92.00K | ||